BPD - Bronchopulmonary Dysplasia
14
4
4
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
7.1%
1 terminated out of 14 trials
83.3%
-3.2% vs benchmark
7%
1 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (14)
Safety and PK-PD Study of Oral L-CIT in Preterm Infants With BPD±PH and NEC
Duodenal Feeds in Very Low Birth Weight Infants
Pressure Targeting During High Flow Therapy in Premature Infants
Controlled Remote Monitoring and Optimization of Oxygen Therapy in Preterm Infants
Early-life MRI Biomarkers of Longer-term Respiratory Morbidity in Infants Born Extremely Preterm (EMBLEM)
Feasibility and Impact of Volume Targeted Ventilation in the Delivery Room
Safety and Efficacy of Umbilical Cord-derived Mesenchymal Stem Cell(MSC) Transplantation in the Treatment of Bronchopulmonary Dysplasia(BPD) in Premature Infants
Impact of Steroid, Diuretic, and Fluid Use on BPD Outcomes
PUFAs in Preterm Infants
Randomized Control Trial: Synchronized Non-invasive Positive Pressure Ventilation Versus Non Synchronized Non Invasive Positive Pressure Ventilation in Extremely Low Birth Weight Infants
Targeted vs Standard Fortification of Breast Milk
Early Caffeine in Preterm Neonates
Autologous Cord Blood Cells for Prevention of BPD in Preterm
Comparison of Primary Extubation Failure Between NIPPV and NI-NAVA